CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in CASI Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q2 2025
- Shares held
- 2.61M
- +361.8K (+16.1%) vs. Q2 2025
- Total value
- $4.33M
- +$1.68M (+63.4%) vs. Q2 2025
- New holders
- 3
- 4 more added
- Sold out
- 5
- 2 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.65M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $909.6K |
| Q4 2023 | 18 | $1.98M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 145 | $0 | 0.00% | +119+457.7% | Added |
| MAI Capital Management | 5 | $9 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $18 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 13 | $22 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14 | $23 | 0.00% | −940−98.5% | Reduced |
| JPMorgan Chase & Co | 25 | $42 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 134 | $222 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 296 | $491 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 365 | $606 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 505 | $838 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,300 | $3.82K | 0.00% | +2,300 | New |
| Royal Bank of Canada | 9,950 | $16.0K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 10,135 | $16.8K | 0.04% | +10,135 | New |
| Geode Capital Management, LLC | 18,808 | $31.2K | 0.00% | 00.0% | Unchanged |
| Wellington Shields & Co., LLC | 30,091 | $50.0K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 33,267 | $55.2K | 0.00% | +33,267 | New |
| Renaissance Technologies LLC | 43,900 | $72.9K | 0.00% | +4,700+12.0% | Added |
| Wellington Shields Capital Management, LLC | 69,535 | $115.4K | 0.02% | −21,310−23.5% | Reduced |
| Woodline Partners LP | 165,640 | $275.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 254,884 | $423.1K | 0.00% | +242,823+2,013.3% | Added |
| Foresite Capital Management VI LLC | 979,956 | $1.63M | 0.63% | +192,835+24.5% | Added |
| VR Adviser, LLC | 987,259 | $1.64M | 0.09% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −44,120−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −36,246−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,599−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,151−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −19−100.0% | Sold out |